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Major histocompatibility complex class I (MHCI) and
MHCII proteins differ in structure and sequence. To
understand how T cell receptors (TCRs) can use the
same set of variable regions to bind both proteins,
we have presented a comparison of a single TCR
bound to both MHCI and MHCII ligands. The TCR
adopts similar orientations on both ligands with
TCR amino acids thought to be evolutionarily con-
served for MHC interaction occupying similar posi-
tions on the MHCI and MHCII helices. However, the
TCR antigen-binding loops use different conforma-
tions when interacting with each ligand. Most impor-
tantly, we observed alternate TCR core conforma-
tions. When bound to MHCI, but not MHCII, Va
disengages from the Ja b strand, switching Va’s
position relative to Vb. In several other structures,
either Va or Vb undergoes this same modification.
Thus, both TCR V-domains can switch among alter-
nate conformations, perhaps extending their ability
to react with different MHC-peptide ligands.
INTRODUCTION
Unlike B cells that bind many different types of antigens, T cells
bearing ab antigen receptors (TCRs) usually react only with
peptides from foreign antigens bound in the grooves of major
histocompatibility complex proteins (MHC). Recent evidence
suggests that this bias toward MHC-presented antigens is
caused by two phenomena: (1) the sequences of TCR variable
regions themselves, which appear to have been selected during
evolution to have some intrinsic affinity for MHC (Jerne, 1971)
and (2) positive and negative selection in the thymus, which
allows the maturation of only those thymocytes that bear TCRsthat react weakly with self MHC+self peptides (Fink and
Bevan, 1978; Zinkernagel et al., 1978). We and others have pub-
lished data supporting the first idea, showing that in mice and
humans the group of TCR variable regions that are related to
the mouse Vb8 or mouse Va4 families have an intrinsic ability
to bind to MHC conferred by three amino acids, Y46, Y48, and
E54, in the complementarity determining region-2 (CDR2)
regions of the Vb8 relatives and Y29 in the CDR1 loops of the
Va4 relatives (Colf et al., 2007; Dai et al., 2008; Feng et al.,
2007; Marrack et al., 2008; Scott-Browne et al., 2009).
Although MHC class I glycoproteins (MHCI) and MHC class II
glycoproteins (MHCII) are related in sequence, they have similar
but not identical structures. The TCR-exposed surface of MHCI
includes two nearly continuous a helices, whereas the a helix of
theMHCII a chain is interrupted by a linear stretch of amino acids
(Bjorkman et al., 1987; Madden, 1995; Madden et al., 1992).
Furthermore, peptides bind to the two MHC classes quite differ-
ently. Peptides bind to MHCII in an extended polyproline-like
mode, sitting low in the binding groove with their ends often
extending beyond the ends of the groove. The peptide binding
groove of MHCI is closed at both ends. Thus, peptides that
bind to MHCI are usually shorter, with their termini buried in
conserved positions at the ends of the groove and the center
of the peptide often bulging up (Engelhard, 1994). These facts,
combined with the observation that TCRs rarely cross react
between MHCI and MHCII, suggest that TCRs might interact
with the two classes of MHC differently. Nevertheless, TCRs
use the same set of variable elements (Vas, Jas, Vbs, Dbs, and
Jbs) to react with MHCI and MHCII, although some individual
variable elements may be used more often for one class than
the other (Sim et al., 1996). Also, the many structures of TCRs
bound to MHCI and MHCII show a similar overall orientation of
the TCRs on the MHC molecules (Rudolph et al., 2006).
Moreover, when these TCRs share a variable element, some of
the same CDR1 and CDR2 amino acids are involved in binding
to MHCI and MHCII (Burrows et al., 2010; Dai et al., 2008;
Feng et al., 2007; Marrack et al., 2008; Rudolph et al., 2006;
Scott-Browne et al., 2009).Immunity 35, 23–33, July 22, 2011 ª2011 Elsevier Inc. 23
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Switchable TCR ConformationsThese observations led us to consider how a single TCRmight
bind to both MHCI and MHCII ligands. Would the TCR amino
acids that we predict to have been built in by evolution to react
with MHC be used similarly in the two interactions? Although
most T cells with this ability are eliminated by negative selection
in the thymus (Huseby et al., 2005; Merkenschlager et al., 1997;
Zerrahn et al., 1997), in mice created to have a single MHCII
molecule covalently bound to a single peptide, many of these
MHC-reactive T cells escape negative selection and populate
the mature T cell repertoire. These T cells often cross react
exuberantly with foreign MHC proteins, and T cells that react
with both MHCI and MHCII are common in such animals
(Huseby et al., 2005; Logunova et al., 2005).
The YAe-62.8 (YAe62) TCR, from a single peptide IAb mouse,
has this ability to recognize both MHCI and various alleles of
MHCII. We recently reported the structure of the YAe62 TCR
bound to the MHCII molecule, IAb, plus a known peptide, p3K
(Dai et al., 2008). However, the nature of YAe62’s cross
reactivity with class I was unknown. Here we identify a peptide
that, when bound to the MHCI molecule Kb, creates a ligand
for the YAe62 TCR. We solved the structure of the YAe62 TCR
bound to Kb-peptide and compared this structure with that of
the same TCR bound to IAb-p3K. The orientation of the TCR
on the two ligands is quite similar and the same four Va and Vb
germline-encoded TCR amino acids, previously reported to be
conserved for MHCII interaction, are involved in binding to
both IAb and Kb. Nevertheless, the YAe62 TCR copes with its
two ligands by varying considerably the conformations of its
CDR3 amino acids, a strategy that has been described by others
for TCRs that react with several ligands of the same class of
MHC (Colf et al., 2007; Mazza et al., 2007).
Unexpectedly, the YAe62 TCR uses an additional strategy, not
previously noted, to deal with the differences between its two
ligands. When bound to the Kb ligand, most of Va has swiveled
away from Vb leaving its Ja b strand behind, to mediate the
conserved interaction with Vb, and changing the angle and posi-
tion of Va relative to Vb. An analysis of more than 40 published
TCR structures shows that this phenomenon has gone unex-
plored in several other cases involving both TCR Va and Vb
domains (Archbold et al., 2009; Housset et al., 1997) We hypoth-
esize that this mechanism gives each TCR three potential alter-
nate conformations, thereby increasing the diversity of the TCR
repertoire and allowing an adjustment of the relationship among
the Va and Vb CDR loops to accommodate various MHC-
peptide ligands.
RESULTS
Identification of a Peptide Mimotope Recognized
by YAe62 Bound to Kb
YAe62 and 3K-36 are two highly cross-reactive T cells, both
produced by immunization with IAb-p3K. Transgenic expression
of these TCRs in H-2b mice lacking IAb leads to the development
of mature CD8+ T cells, suggesting that, despite their MHCII
reactivity, these TCRs can be positively selected on H-2b
MHCI molecules and thus might react with an H-2b MHCI-
presented antigen. For 3K-36, this idea was confirmed by iden-
tification of mimotope peptides that could activate CD8+ 3K-36
T cells when presented by Kb (Huseby et al., 2005). In this24 Immunity 35, 23–33, July 22, 2011 ª2011 Elsevier Inc.previous study a peptide was not discovered for YAe62 CD8+
T cells, but they were shown to be activated by MHCII– cells
bearing MHCI from H-2k, but not H-2b or H-2q, strongly
suggesting a capacity for MHCI-peptide reactivity by YAe62, in
this case to an allo-MHCI antigen.
We revisited the question of the MHCI specificity of the YAe62
TCR via positional scanning (Pinilla et al., 1992) to screen
a nonamer peptide library for peptides able to activate YAe62
CD8+ T cells from MHCII– mice. After deconvoluting the
resultant data, candidate peptides were synthesized and
tested for their ability to activate YAe62 CD8+ T cells. Several
semipurified 9-mer peptides with a high degree of sequence
homology were found to activate the cells. However, when highly
purified versions of these peptides were tested, they each failed
to activate the T cells. A common contaminating 8-mer peptide,
WIYVYRPM (pWM), was identified by mass spectrometry in the
semipurified peptide preparations and was then synthesized de
novo. The proliferative responses of CD8+ T cells from Yae62
and 3K-36 TCR transgenic mice to pWM, p3K, and pVL
(a 3K-36 mimotope peptide) were tested with H-2b, MHCII– pre-
senting spleen cells (Figure 1A). The YAe62 T cells responded
strongly to pWM, but not at all to p3K or pVL, whereas the
3K-36 T cells responded to pVL, but not pWM or p3K,
confirming the specificity of YAe62 for pWM. To find out which
H-2b MHCI molecule presented pWM, we tested activated
YAe62-bearing CD8 T cells from YAe62 TCR transgenic, MHCII–
mice for pWM-dependent cytotoxic activity on MHCII– targets
expressing either Kb or Db. Cells bearing IAb-p3K were used as
positive controls. The results showed that YAe62 recognized
pWM presented by Kb, but not Db (Figure 1B).
To study the interaction of the Kb-pWM complex with
the YAe62 TCR directly, we produced soluble versions of
each in baculovirus-infected insect cells (see Supplemental
Experimental Procedures available online). In brief, pWM
was expressed covalently linked to the N terminus of b-2
microglobulin (b2m) via a flexible linker. To improve the stability
and homogeneity of the complex, a disulfide bond was
introduced by placing cysteines in the linker and in substitution
for Tyr84 in the Kb heavy chain (Lybarger et al., 2003).
Similarly, as a negative control, Kb was prepared bearing the
ovalbumin peptide SIINFEKL (pOVA). In each case the protein
carried a biotinylation tag at the MHC heavy-chain C terminus.
As a positive control, we used a biotinylated version of soluble
IAb-p3K. As described in the Supplemental Experimental
Procedures, the ability of the purified Yae62 TCR to bind the
three MHC complexes was assessed by surface plasmon
resonance with a BIAcore 2000 instrument (Figure 1C). The
TCR bound both IAb-p3K and Kb-pWM with very rapid kinetics
(first and seconds panels) but did not bind Kb-pOVA (third
panel). The equilibrium binding data were used to calculate the
affinity of the two ligands for the TCR (fourth panel). As
previously reported, YAe62 had a KD of about 9 mM for IAb-
p3K (Huseby et al., 2006). It bound less strongly to Kb-pWM,
with a KD of about 15 mM.
General Orientation and Footprint of the YAe TCR
on IAb-p3K versus Kb-pWM
For crystallography, the YAe62 TCRwas expressed in E. coli and
refolded and purified as previously described (Dai et al., 2008;
BA
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Figure 1. Identification of a Kb Bound Mimotope Recognized by the YAe62 TCR
(A) The proliferative responses (3H-TdR incorporation) of CD8+ T cells from either YAe62 or 3K-36 TCR transgenic, MHCII– mice (Huseby et al., 2005) to various
peptides presented by spleen cells from H-2b, MHCII– mice were measured as described in Supplemental Experimental Procedures. pVL (VIKWWRRL) is
a peptide mimotope specific for the 3K-36 TCR. Similar results were obtained in two other similar experiments.
(B) The ability of activated CD8+ T cells from YAe62 TCR transgenic mice to lyse 3T3 fibroblasts transduced with either Kb or Db was measured as described in
Supplemental Experimental Procedures. Cells expressing IAb covalently bound to p3K were used as the positive control. The results of a single experiment are
shown.
(C) Approximately 3000 resonance units (RU) of biotinylated versions of IAb-p3K, Kb-pMW, and Kb-pOVA, as well as an irrelevant MHC molecule, HLA-DR52c,
were immobilized in the four flow cells of a BIAcore streptavidin biosensor chip. Various concentrations of soluble YAe62 TCRwere injected through the four flow
cells for 30 s. The three panels at the left show the binding of YAe62 TCR to the three ligands (RU) versus time after correction for the fluid phase surface plasmon
resonance signal in the flow cell containing the immobilized control DR52c protein. The net equilibrium RU signals were used to create Scatchard plots for the
IAb-p3K and Kb-pWM ligands (right). The least-squares regression line fit to the data was used to estimate the overall affinity (KD) of the TCR for IAb-p3K and
Kb-pMW. Similar results were obtained in two similar experiments.
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Switchable TCR ConformationsTynan et al., 2007). Kb and b2m covalently bound to pWM were
coexpressed in baculovirus-infected insect cells as above, but
without the biotinylation tag. An equimolar mixture of the two
purified proteins was crystallized by the hanging-drop vapor
diffusion method (Experimental Procedures). The complex
crystallized in two space groups, I222 and P3221. We solved
the structure of the complex in both crystals by molecular
replacement. Despite the differences in crystal packing, the
TCR interaction with Kb-pWM was nearly identical in both
initial models. Therefore we solved the higher-resolution struc-
ture to a final resolution of 2.9 A˚. The properties of the crystals
and details of the data collection, solution, and refinement are
in the Supplemental Experimental Procedures and Table S1.
Figure 2 shows the general orientations and footprints of the
YAe62 TCR on Kb-pWM and IAb-p3K. When viewed from
above, the receptor has the now familiar diagonal orientationon both ligands but has a slightly shifted position on Kb-pWM
compared to IAb-p3K (Figure 2A). However, when viewed from
the N-terminal end of the bound peptides, the TCR sits
somewhat flatter on Kb-pWM than on IAb-p3K (Figure 2B). This
results in a larger footprint of the TCR on Kb-pWM (1529 A˚2)
than on IAb-p3K (1178 A˚2) (Figure 2A; Dai et al., 2008). A
summary of TCR atom-to-atom contacts with the two ligands
is displayed in Table 1 and a complete list of these contacts for
the Kb-pWM ligands is included in Table S2. A similar list for
the IAb-p3K ligand was previously published (Dai et al., 2008).
Despite the larger area of contact, the amino acids of the TCR
make many fewer atom-to-atom contacts with the Kb-pWM
ligand than with IAb-p3K, perhaps accounting for the lower
affinity of the TCR for Kb-pWM. In both cases, the interface
between the TCR and the ligand is dominated by van der Waal’s
interactions rather than salt bridges or hydrogen bonds.Immunity 35, 23–33, July 22, 2011 ª2011 Elsevier Inc. 25
BA Figure 2. Orientation and Footprint of the
YAe62 TCR on Its MHCI and MHCII Ligands
(A) Left: Top view of the water-accessible surface
of the peptide plus the a1 and b1 IAb domains is
shown with the following color scheme: helix of the
a1 domain, cyan; helix of the b1 domain, magenta;
the rest of IAb, white; p3K peptide, yellow. The
footprint of the YAe62 TCR on this ligand is shown
by coloring MHC-peptide atoms within 4.5 A˚ of the
TCR with darker versions of the same colors. The
YAe62 CDR loops are represented as tubes, Va
(red) and Vb (green). Right: Ribbon representation
of the Va and Vb domains of the YAe62 TCR bound
to the IAb-p3K complex, Va, red; Vb, green; IAb a1,
cyan; IAb b1, magenta; and p3K, yellow.
(B) As in (A), but with the a1 and a2 domain of Kb
and pWM instead of the a1 and b1 IAb domains
and p3K.
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Switchable TCR ConformationsSimilar Use of Conserved CDR1 and CDR2 Amino Acids
in the Two Structures
There are both similarities and differences in how the YAe62
CDR1 and CDR2 loops contact the MHCI and MHCII ligands.
The tilt of TCR toward the a1 helix of IAb-p3K greatly accentuates
ligand interaction with Vb at the expense of Va (Table 1; Dai et al.,
2008). In the IAb-p3K complex, CDR1bmakes almost no contact,
but there is a tight cluster of interaction between Y46, Y48, and
E54 of CDR2b and the IAb a1 domain. On the IAb b1 helix, Y29
of CDR1a is the main point of contact. These four amino acids
are also involved in the interaction of YAe62 with its Kb-pWM
ligand, contacting positions on the MHCI helices that are
similar to YAe’s contact positions on MHCII. They have been
seen repeatedly contacting similar positions on MHCII
molecules in a variety of TCR-MHCII structures involving mouse
Vb8 and Va4 and related V-regions in mouse and humans and
are important for MHCII-mediated CD4 T cell thymic selection.
Vb Y46 and Y48 and Va Y29, when they are present, are also
often involved in interactions with MHCI. Therefore, we and
others have suggested that these TCR V region amino acids
are evolutionarily conserved for MHC interaction (Dai et al.,26 Immunity 35, 23–33, July 22, 2011 ª2011 Elsevier Inc.2008; Feng et al., 2007; Maynard et al.,
2005; Scott-Browne et al., 2009).
For CDR1a, in both the IAb-p3K and Kb-
pWM complexes, the aromatic ring of Y29
interacts with a flat orientation on the IAb
b1 helix and the Kb a2 helix, respectively
(Figure 3A). However, to maintain this
type of interaction with the Kb helix,
Y29 has rotated about its a carbon-b
carbon axis about 90 compared to its
conformation on the IAb helix, nestling
between Kb A158 and T163, as opposed
to IAb H81b and T77b. The lack of an
amino acid side chain at G162 of Kb
facilitates this approach of Y29 to the Kb
a helix.
In CDR2b, Y48 is a major contributor to
both MHCI and MHCII engagement,
making numerous contacts to bothligands (Figure 3B; Table 1). Like Va Y29, the aromatic ring of
Vb Y48 interacts intimately, in a flat orientation, with a similar
position on the a1 helix in both structures, facilitated by the
lack of an interfering side chain at the adjacent helix position,
G69 in the case of Kb and A64 in the case of IAb. A number of
previous studies have reported that Vb Y48 interacts with
MHCII in this way, confined to a very precise location, nestled
among amino acids 57, 60, 61, and 64 of the a helix (Feng
et al., 2007; Marrack et al., 2008). Vb Y48 has been observed
interacting with a similar location on MHCI in a number of struc-
tures involving TCRs related to mouse Vb8, but in this case it is
allowed to roam over a wider area of the exposed a helix on
the a1 helix (Figure S1; Garcia et al., 1998; Miller et al., 2007;
Speir et al., 1998; Tynan et al., 2007).
The position and orientation of Vb Y46 is almost identical in the
two structures, with its aromatic ring at right angles to that of Y48
(an often-seen stable orientation for the interaction of two
aromatic amino acids) (Figure 3B). In both structures, Y46
makes much less contact with the ligand than does Y48, in
each case involving a single MHC amino acid side chain of the
a1 helix (Q65 for Kb and Q57 for IAb). One possibility is that the
Table 1. Summary of Contacts between the YAe62 TCR and Its
Ligands
Atom-to-Atom Contacts
TCR
MHC
Domain Peptide
MHC
Domain
CDR Amino Acid Aba1 Kba1 p3K pWM Abb1 Kba2
a1 T27 - - 1 4 1 1
G28 - - 1 6 - -
Y29 - - 5 - 29 7
a2 T50 - - - - - 4
T51 - - - - 2 5
a3 S93 - - - 1 - -
G94 - 5 - - - -
T95 8 3 - - - -
Y96 - 7 - - - -
b1 N26 - - 1 - - -
N28 2 19 3 - - -
N29 5 - - - - -
b2 Y46 7 2 - - - -
Y48 53 38 - - - -
G49 - 6 - - - -
A50 - 7 - - - -
T53 2 - - - - -
E54 28 1 - - - -
b3 D93 - - - 7 - -
F94 40 - 3 15 - 9
W95 48 17 31 7 3 -
Total 193 105 45 40 35 26
A
B
C
Figure 3. Conserved Amino Acids in the YAe62 CDR1a and CDR2b
Contact Both Ligands
The interactions between the YAe62 CDR1a containing aY29 (A), the portion of
CDR2b loop containing bY46 and bY48 (B), or b54E (C) with either IAb-p3K (left)
or Kb-pWM (right) are shown. In all panels the TCR loop and the MHC-peptide
are represented as a carbon traces with wireframe representations of key
amino acid side chains.
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Switchable TCR Conformationsability of Y46 to orient and support Y48 might be more important
than its direct contact with MHC.
With MHCII ligands such as IAb-p3K, CDR2b E54 contacts
a conserved Lys on a loop connecting MHCII a1 b strands 3
and 4 (Figure 3C). Because this site does not exist in MHCI
ligands, it is not surprising that Vb E54 is often not seen in
contact with MHCI for TCRs bearing Vbs related to mouse
Vb8. However, in the YAe62-Kb-pWM structure, there is a single
contact between YAe62 E54 and the Kb a1 helix, and in two other
cases involving a Vb8 TCR (PDB 1LP9 and 1G6R), E54 has been
observed in contact with an MHCI a1 helix.
To compare the relative contribution of these four amino acids
to the binding of the YAe68 TCR to the two ligands, we intro-
duced the YAe62 TCR, and mutants in which these four amino
acids were individually changed to alanine, into a T cell
hybridoma lacking any endogenous TCR chains, as previously
described (Scott-Browne et al., 2007). The resultant T cell
hybridomas were sorted by flow cytometry for roughly
equivalent surface expression of their TCRs and costained with
fluorescent anti-Cb and tetramers made up of either IAb-p3K or
Kb-pWM. Cells were gated on populations with equivalent Cb
staining, and the mean fluorescence intensity (MFI) of tetramer
staining was calculated. The data are shown in Figure 4. All
four mutations had a dramatic effect on tetramer binding, once
again confirming their critical role in MHC interaction. The
effects of mutating additional Vb amino acids to alanine on thebinding of the YAe62 TCR to Kb-pWM and IAb-p3K are shown
in Figure S2.
Because of the larger footprint of the YAe62 TCR on Kb-pWM
versus IAb-p3K, more CDR1 and CDR2 amino acids contribute
to the TCR footprint on Kb-pWM than on IAb-p3K despite the
overall fewer atom-to-atom contacts (Table 1). For example, in
CDR2b, Y48 and E54 are the major amino acids contributing to
engagement of IAb-p3K, but for the Kb-pWM ligand CDR2b,
G49 and A50 also contribute considerably. In CDR2a, only T51
contacts IAb, but both T50 and T51 contact Kb.
CDR3 Loop Adjustments to the Two Ligands
The CDR3s of both Va and Vb interact quite differently with
IAb-p3K than with Kb-pWM (Figure 5; Table 1; Table S2). In the
IAb-p3K structure, only T95 in CDR3a makes contact, albeit
minimally, with Q58 and Q62 of the IAb b chain, but in the Kb-
pWM structure, the entire tip of CDR3a (S93, G94, T95, and
Y96) makes multiple contacts with both Kb (Q65 and K66) andImmunity 35, 23–33, July 22, 2011 ª2011 Elsevier Inc. 27
Figure 4. Four Conserved YAe62 TCR Amino Acids Are Essential for
Recognition of Both IAb-p3K and Kb-pWM
A TCR– T cell hybridoma was transduced with retroviruses encoding either the
genes for the wild-type (WT) YAe62 TCR or mutated genes to change indi-
vidually aY29, bY46, bY48, or bE54 to alanine (Supplemental Experimental
Procedures). The ability of fluorescent tetramers of IAb-p3K or Kb-pWM to
bind to the TCRs on these cells was assessed by flow cytometry, costaining
with a Cb-specific mAb. The results are shown as the mean channel
fluorescence obtained with the tetramers on the ab transduced cells minus
that seen on cells transduced with the WT b chain gene only, expressed as
the percent of the results with the unmutated TCR. The average ± SEM of
three experiments is shown.
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Switchable TCR Conformationsthe p1W of the peptide (Figure 5A). To accomplish this there also
is a considerable conformational change in the CDR3a loop
backbone between the two structures. Because, typical of
MHC class I bound peptides, the middle of the pWM peptide
sits about 2.5 A˚ higher in the peptide binding groove of Kb than
p3K does in IAb, it is not surprising that CDR3b has undergone
major conformational changes to accommodate this more
intimate proximity of the middle of the peptide (Figure 5B). In
the IAb-p3K structure, Vb W95, at the tip of CDR3b, slots
between the peptide and the IAb b chain helix, making a major
contribution to the overall interface. However, in Kb-pWM, to
accommodate the higher position of the peptide, the side
chain of W95 swings up and out over the Kb a1 helix, making
much less overall contact with both the MHC and peptide
(Figure 5B). This change in the orientation of CDR3b W95, and
also that of CDR3b F94, is permitted by flattening the
backbone of CDR3b itself, again illustrating the flexibility with
which CDR3 regions adjust to different ligands (Gagnon et al.,
2006; Reiser et al., 2003).
Three Alternate Conformations of the Core TCR
Structure
The most striking structural change in the YAe62 TCR in binding
to Kb-pWM versus IAb-p3K is a disruption in the b strand core of
Va.When bound to IAb, the core of theYAe62Vadomain consists
of two b strand sheets, typical of immunoglobulin family V
domains. One sheet is composed of four b strands (1, 2, 6, and 7)
and the other of five b strands (3, 4, 5, and 8 from Va with 9 from
Ja). Also typical of immunoglobulin family V domains, the interac-
tion between the long Va b strand 8 and the b strand of Ja is
interrupted at the conserved FGXG Ja motif (Figure 6A, left).
However, when bound to Kb-pWM, the lower portion of this
interaction is disrupted, breaking three H-bonds, but preserving
the interactions between the upper portions of the strands28 Immunity 35, 23–33, July 22, 2011 ª2011 Elsevier Inc.(Figure 6A, right). The side chain of Q97 now swings in to fill the
gap, stabilizing the structure by bridging the two b strands with
an H-bond to each strand. This conformational change is
clearly seen in the electron density in this region of the TCR
(Figure S3A).
The net result of this change in conformation is that the portion
of the Va domain containing CDR1 and CDR2 swings out away
from Vb (Figure 6B), while not disturbing the portions of the Ja
and Va b strands 3 (Figure 6B) that stabilize the hydrophobic
core of the Va to Vb interface that includes F99 of the FGXG
motif (Figure 6C). The second glycine (G102) in the FGXG motif
is the pivot point of the Va movement and it is likely that the
rotational flexibility of the two glycines in the motif allows Va to
undergo this conformational change.
When the two versions of the TCR are superimposed based on
the Vb domain, and the CDR1 and CDR2 loops are viewed from
above down the center of interaction between Va and Vb
(Figure 6D), one can see that this alternate conformation of the
TCR allows the Va CDR1 and CDR2 loops to rotate about
10–12 in relation to Vb, changing the relative positions of the
Va and Vb CDR1 and CDR2 loops in relation to each other by
more than 4 A˚.
The FGXG motif is conserved in nearly all TCR J elements, so
we examined published TCR-MHC structures to see whether
this type of conformational change may have been present but
not explored in the published structures. We superimposed
separately the Va and Vb domains of more than 40 reported
mouse and human TCR structures, involving more than 40
different TCRs (Figures S3B and S3C). In most of these, the J
region b strand has the conventional position in the Va or Vb
domains. However, we found examples in which the J to V
interaction undergoes a conformational change that was
remarkably similar to that seen in the YAe62 TCR bound to
Kb-pWM, one set involving human Va4 (hTRAV24) and
a second involving mouse Vb2 (mTRBV1).
There are seven structures involving three TCRs (four for LC13,
two for DM1, and one for KK50) that contain members of the
human Va4 family, but each TCR uses a different Ja element
(TRJA 52, 13, 37, respectively). In five cases the TCRs are bound
to human MHCI ligands (PDB 3KPR, 3KPS, 1MI5, 3DXA, and
2ESV) and in the other two cases the LC13 (PDB 1KGC) and
DM1 (PDB 3DX9) TCRs were solved in an unbound form
(Archbold et al., 2009; Hoare et al., 2006; Kjer-Nielsen et al.,
2002, 2003; Macdonald et al., 2009). In all seven examples the
Va4 domain has almost the same conformation as that in the
YAe62 TCR bound to Kb-pWM (Figure S3B). An example is
shown for the bound (Figure 6E, left) and unbound (Figure 6E,
right) DM1 TCR. In both cases, the Ja b strand the TCR
matches the disrupted conformation seen with the YAe62
bound to Kb-pWM rather than to IAb-p3K. The upper part of
the interaction between these strands is intact, but the strands
are separated at the second glycine (G118) of the FGXG motif
in a manner very similar to that of the YAe62 TCR bound to
Kb-pWM (Figure 6A, right).
Because this transformation is seen in the unbound DM1 TCR
structure, it seems likely that, in contrast to the bulk of studied
TCRs, this altered open conformation is preferred prior to ligand
engagement for this TCR. Because these three TCRs all use
different Ja elements and have very different CDR3a lengths
AB
Figure 5. Major Conformational Changes in
the CDR3 Loops of the YAe62 TCR when
Bound to IAb-p3K versus Kb-pWM
The interactions of the CDR3a (A) and CDR3b (B)
loops of the YAe62 TCR with IAb-p3K (left) and
Kb-pWM (right) are shown. Portions of the CDR3
loops and the MHC-peptide are represented as
a carbon traces with wireframe representations of
key amino acid side chains.
Immunity
Switchable TCR Conformationsand sequences, we considered whether the preference for this
conformation might be inherent in the human Va4. A unique
feature of human Va4 is the presence of an isoleucine (I105)
immediately after the universally conserved cysteine in Va
b strand 8 (Figure 6E). In nearly all other human and mouse Va
elements, including all of those found in other published
structures of MHC-peptide reactive TCRs, this amino acid is
an alanine. Its position in all of the human Va4 structures puts
its bulky side chain in juxtaposition to the conserved phenylala-
nine of the FGXG motif of Ja. This could interfere with the transi-
tion to the conventional conformation, explaining the predilec-
tion of human Va4 for the more open conformation.
There are five structures involving mouse Vb2 containing
TCRs, three for the Bm3.3 TCR (PDB 1FO0, 1NAM, and 2OL3)
and two for the KB5-20 TCR (PDB 1KB5 and 1KJ2) (Housset
et al., 1997; Mazza et al., 2007; Reiser et al., 2000, 2002). The
TCRs contain different Jb elements, TRBJ1-3 and TRBJ2-3,
respectively. The Bm3.3 TCR was solved bound to three
differentMHCI-peptide complexes. In all of these, the Jb b strand
interacts with Vb b strand 8 in a closed conformation, very similar
that seen in other Vb domains (Figure S3C).
However, the exception is the KB5-20 TCR, which was solved
bound to a Kb-peptide complex and, in an unbound state, com-
plexed with a monoclonal antibody Fab (Housset et al., 1997;
Reiser et al., 2002). In the unbound KB5-20 TCR structure
(Figure 6F, left), the Jb b strand interaction with Vb b strand 8
is nearly identical to that seen in the Bm3.3 structures and in
other TCR Vbs. But, as pointed out by the authors who
reported these structures, the extra-long CDR3b at the end of
these b strands undergoes a tremendous conformational changeImmunity 35, 2upon binding the ligand, collapsing from
an extended configuration to a compact
one. This change upon binding is accom-
panied by the separation of the Jb b strand
and Vb b strand 8 that mirrors almost
identically the conformational change
seen in Va in the human Va4 TCRs and
in the YAe62 TCR bound to Kb-pWM
(Figure 6F, right). The lower part of Jb
separates from Vb precisely at the
second glycine (G111) of the FGXG
motif, breaking the lower interchain H-
bonds. Again, the bulk of the Vb domain
containing CDR1 and CDR2 has
separated from the b strand of Jb, which
maintains its conserved interaction with
Va. Again, mirroring the case with the
YAe62 TCR, when the two versions ofthe KB5-20 TCR are superimposed based on the Va domain,
and the CDR1 and CDR2 loops are viewed from above down
the center of interaction between Va and Vb (Figure 6G), one
can see that the Vb CDR1 and CDR2 loops of the ligand bound
KB5-20 TCR rotate 8–9 in relation to those of Va, and the rela-
tive positions of the Va and Vb CDR1 and CDR2 loops move by
more than 4 A˚. Perhaps because there were so few TCRs for
comparison at the time, the authors attributed these structural
changes to an unusual situation forced by the collapse of an
extra-long CDR3b loop (16 amino acids) upon ligand engage-
ment. However, the Va CDR3 loop of YAe62 is the shortest of
the solved TCRs (8 amino acids) and the human Va4-
containing TCRs assume the open conformation whether or
not they are ligated, suggesting that this structural flexibility is
inherent in TCR V domains.
Taken together, these structures suggest that in addition to
adjustments in the rotomers of individual CDR amino acids and
conformational changes in the backbones of CDR loops, a given
TCR may switch among at least three distinct alternate confor-
mations depending on whether the VaJa or VbJb connection is
disrupted (Figure 6H). In each case, the core JaJb interaction
is not disrupted, but the relation among the CDR1 and CDR2
loops of Va and Vb changes. Also, since the disrupted strands
support a CDR3 loop, this CDR3 is stretched and changes
shape. Whether a fourth conformation involving simultaneous
disruption of Va and Vb is possible is unknown. However, it
might not be possible to preserve the core JaJb interaction
in such a case. Switching among these three alternate
conformations can extend the size of the TCR repertoire and
may allow the TCR to maintain the conserved points of3–33, July 22, 2011 ª2011 Elsevier Inc. 29
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Figure 6. Alterations in the Relative Orientation of Va to Vb Extend the Ability of the TCR to Accommodate Different MHC Ligands
(A) The disruption of the b strand interactions between Ja and Va of YAe62 when it is bound to Kb-pWM versus IAb-p3K is shown. A wireframe representation of
the protein backbone of Ja and the last b strand of Va with the side chains for the FGXG conserved motif and aQ97 are shown. Backbone H-bonds, as well as
those involving aQ97, are shown in green.
(B–D) The Va and Vb domains of the YAe62 TCR bound to IAb-p3K (Va, cyan; Vb, green) versus Kb-pWM (Va, yellow; Vb, magenta) were overlaid by Vb.
(B) The TCR Va and Vb are represented as ribbons. The rotation of Va in relation to Vb (arrow) is shown.
(C) The unchanged positions of the four core aromatic amino acid at the Va to Vb interface are shown for the two TCRs.
(D) A view looking down through the TCR toward the ligands is shown with the CDR1 and CDR2 loops as Ca traces and the positions of the Ca carbon of a central
amino acid on each loop labeled. The relative distance and angle of movement of these atoms on the Va loops relative to the adjacent Vb atoms is indicated.
(E) The b strand interactions between Ja and Va for a representative, DM1 (Archbold et al., 2009), of the three human TCRs bearing Va4 family members whose
structures have been published is shown as in (A), either unbound (left) or bound (right) to an MHCI ligand. Side chains for the FGXG conserved motif and for
aC104 and aI105 are shown and labeled.
(F) Same as (E) but for the mouse Vb2 bearing TCR, Kb5 (Housset et al., 1997; Reiser et al., 2002).
(G) Same as (D) except that the two Kb5 TCRs are overlaid by Va rather than Vb.
(H) A cartoon representation of the relative range in orientation of Va to Vb in this and other published TCR structures.
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Switchable TCR Conformationsinteraction with MHC with a variety of different MHC alleles,
isotypes, and classes that differ substantially both in sequence
and the spacing between the helices.
DISCUSSION
When the first structures of abTCRs bound to MHC ligands ap-
peared, the hope was that they would answer the question of
why TCRs are confined to MHC ligands. We expected to see
easily identifiable conserved interactions of the TCR CDR1 and
CDR2 loops with the MHC helices, explaining the evolutionary30 Immunity 35, 23–33, July 22, 2011 ª2011 Elsevier Inc.connection between the TCR and MHC. It has taken 15 years
and dozens of TCR-MHC structures to understand that the
‘‘rules of engagement’’ between TCRs and MHC ligands are
much more complicated than originally imagined. Their interac-
tions are not conserved in the conventional structural sense,
but rather allow for considerably more flexibility, within the
confines of certain general rules.
One of these rules has been well established. In all structures
solved so far, the TCR has a diagonal orientation on the MHC
(reviewed in Rudolph et al., 2006). The CDR loops of the TCR
usually occupy similar sites in the different structures, with the
Immunity
Switchable TCR ConformationsCDR2 loops interacting particularly with the MHC a helices and
the very variable CDR3 loops centered on the peptide,
whereas the CDR1 loops often contact both peptide and MHC.
This rule applies for both MHCI and MHCII ligands and can be
seen in the structure of the YAe62 TCR bound to either
IAb-p3K or Kb-pWM. However, within this rule there is
considerable latitude in the angle of engagement when viewed
from above, in the pitch and yaw when viewed from the side or
down the axis of the peptide binding groove (Bjorkman, 1997;
Rudolph et al., 2006; Sethi et al., 2011) and, in few extreme cases
involving some autoimmune TCRs, in the position of the TCR
along the length of the peptide (Hahn et al., 2005; Li et al.,
2005). Accordingly, there are some differences in the angle
and yaw of the YAe62 TCR when bound to Kb-pWM compared
to IAb-p3K.
With the accumulation of more structures of bound versus free
TCRs, individual TCRs bound to different ligands, and different
TCRs with the same V element, it has also become clear that
the general orientation of the TCR on theMHC involves consider-
able flexibility in the TCR CDR loops, especially the CDR3 loops
(Gagnon et al., 2006; Reiser et al., 2003). The loops adjust to
different ligands by changing not only the rotamers of their amino
acid side chains, but also the conformation of their main chain
backbones. This point is well illustrated in the structures pre-
sented here. There are numerous differences in the rotamers of
particular CDR amino acids of the YAe62 TCR when engaging
its MHCI versus MHCII ligand. Changes in backbone conforma-
tion of the CDR3 loops are particularly extensive.
The semiconserved orientation of the TCR on MHC has raised
the question of whether there are specific germline-encoded V
region amino acids selected evolutionarily to be linchpin posi-
tions for MHC interaction, thus imposing this orientation. The
answer to this question has been harder to tease out from the
structural data, because it requires comparison of a substantial
set of structures involving different MHC ligands and TCRs, all
of which have the same TCR Va and/or Vb element. This require-
ment has been met for only a handful of V elements, such as
those related tomouse Vb8 and Va4 discussed here and present
in the YAe62 TCR. These V elements contain four amino acids
that repeatedly have been observed to interact with the MHCII
helices at the same locations (Dai et al., 2008; Feng et al.,
2007; Maynard et al., 2005). Those interactions are particularly
well illustrated in the YAe62 complexes with IAb-p3K. We find
the same amino acids in similar positions on the Kb-pWM ligand
and their mutation dramatically reduced YAe62 binding to both
ligands. It is noteworthy that two of these amino acids are tyro-
sines (aY29 and bY48), whose interaction with the MHC does
not require the precise geometry seen in H-bonds, but is depen-
dent rather on the ability of their aromatic ring to create
a substantial area of Van der Waals interaction, thus contributing
to flexibility in the details of the contact. In both cases the
approach of these amino acids to the MHC helix is facilitated
by adjacent MHC amino acids lacking an interfering side chain.
Whether the presence of conserved germline-encoded MHC
interactions will extend to most other V elements will depend
on many more new TCR-MHC structures and probably take
many years to work out. It could be argued that, given the vari-
ability of the TCR angle, pitch, and yaw on MHC, these
germline-encoded interactions will prove to be rare. However,we have seen a very high frequency of highly MHC crossreactive
T cells, such as YAe62, developing in single peptide mice that
have limited negative selection (Huseby et al., 2005). We argue
that the processes of positive and negative selection in the
thymus of normal animals select against these T cells, whose
TCRs may display a full set of germline-encoded interactions
and therefore be likely to be strongly self-reactive. Rather, these
processes select for TCRs whose somatically generated CDR3
loops interfere with some, but not all, of the possible germline
interactions, steering the TCR specificity toward the peptide
while preserving the TCR orientation on MHC via a much lower
MHC affinity.
The most unexpected finding in the present study was
a substantial disruption of the conventional Ja connection to
Va in the YAe62 TCR when bound to Kb-pWM as compared to
IAb-p3K. This type of Va domain conformational change has
not been previously discussed. Nevertheless, our reexamination
of previously published TCR structures turned up several exam-
ples of a similar altered conformation, one in a Va and one in a Vb
element (Housset et al., 1997; Mazza et al., 2007; Reiser et al.,
2000, 2002). In each case the J region b strand had separated
from the rest of the V element, preserving the critical Va to Vb
interactions mediated by the two J region b strands. Also in
each case, the flex point for this separation is the second glycine
in the FGXGmotif of the J element, raising the possibility that this
motif in TCR J elementsmay be conserved to function as a swivel
point for adjusting the interaction of Va and Vb. The result of
these conformational changes is to alter the positions of the
CDR1 and CDR2 loops of Va relative to those of Vb, influencing
how these loops approach the MHC helices. This type of adjust-
ment may be used in fine tuning the alignment of the CDR1 and
CDR2 loops with particular regions of the MHC helices and also
in accommodating MHC molecules with different distances
between the two helices. The b strands of J and V involved
support the CDR3 loop, so their repositioning also plays a role
in the flexibility of this CDR3.
In the examples so far, this type of conformational change has
been seen only in TCRs that interact withMHCI ligands. Thismay
be coincidental, because there are many more TCR-MHCI than
TCR-MHCII solved structures. Alternatively, the observation
that the positions of the interactions of the amino acids
conserved for MHC interaction are more consistent on MHCII
ligands than on MHCI ligands may indicate that this additional
flexibility in the TCR is more important for proper placement of
these amino acids onMHCI ligands. Thus far, all of the examples
of this conformational change in Va involve TCRs constructed
with a human Ca. Whether this Ca influences the ability of the
Va to undergo this change cannot be determined from these
structures. However, we can say that the human Ca does not
automatically induce this change, because there are many
TCR structures with human Ca with attached Vas in the closed
conformation, including that of the YAe62 TCR bound to
IAb-p3K.
Unlike B cells that use antigen-selected somatic mutation of
their rearranged immunoglobulin genes to vastly increase their
repertoire and fine tune their specificity for antigen, the T cell
repertoire is limited by the set of initial rearrangements of TCR
genes. Given that this repertoire is further constrained by the
requirement for MHC reactivity and the processes of thymicImmunity 35, 23–33, July 22, 2011 ª2011 Elsevier Inc. 31
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Switchable TCR Conformationspositive and negative selection, there is a problem of how the
limited numbers of TCRs in any given animal can cope with the
very large number of MHC-peptide combinations with which
they may be confronted. This problem appears to have been
solved in part by the relatively low affinities needed for TCR inter-
action with MHC-peptide to trigger response in T cells. In addi-
tion, the great flexibility of the CDR regions of TCRs allows
a single TCR to bind a number of ligands. Here we have uncov-
ered another phenomenon that allows recognition of more than
one ligand by a single TCR: the potential to switch among three
alternate conformations by disrupting the J to V interaction of
either the Va or Vb domain.
EXPERIMENTAL PROCEDURES
Identification of Peptide Mimotopes
CD8+ YAe62 TCR transgenic spleen cells were incubated with MHC class
II-deficient spleen cells pulsed with varying doses of a nonapeptide positional
scanning library (N-terminal and C-terminal free, TPI 921) (Pinilla et al., 1992).
Proliferative responses were compared to control wells and ranked and
deconvoluted. Mass spectrometry and further examination revealed
a stimulatory 8-mer peptide, WIYVYRPM (pWM). Cytotoxicity assays were
done by standard techniques (Huseby et al., 1999). Mice were housed in the
National Jewish Biological Research Center and were used under the
oversight and with protocols approved by the National Jewish Institutional
Animal Care and Use Committees.
Protein Expression and Purification
The DNA encoding Kb (extracellular domains) and b2m covalently attached to
pWM or the OVA SIINFEKL peptide (pOVA) were mutated to introduce
cysteines into Kb replacing tyrosine 84 and into the linker that attaches b2m
to pWM replacing a glycine at position 2 (Lybarger et al., 2003) and were
expressed in baculovirus-infected insect cells. Soluble YAe62 TCR was
expressed in baculovirus as previously described (Dai et al., 2008). For
crystallography, the Va and Vb portions of the YAe62 TCR were produced
fused to the extracellular portions of human Ca and Cb, respectively, in
E. coli inclusion bodies (Dai et al., 2008).
Crystal Production and Data Collection
An equimolar mixture of YAe62 TCR and Kb-pWM was crystallized by mixing
0.5 ml of complex solution at a concentration of 15 mg/ml with an equal volume
of reservoir solution. The complex crystallized in two different space groups.
Structure Determination
The structures of YAe-Kb-pWM complex were determined by molecular
replacement with the program Phaser with the YAe62 TCR (PDB 3C60) and
Kb-pdEV8 (PDB 2CKB) as search models, respectively, and manually fitted
with program Coot followed by alternating simulated annealing, positional
refinement, and B factor refinement via the program Phenix.
Structure Analysis
Buried molecular surface areas were calculated with GRASP. NCONT in CCP4
was used to analyze the contacts between the TCRs and their ligands.
TCR Mutational Analysis
The contribution of TCR amino acids to ligand recognition was measured by
retroviral transduction of a TCR– hybridoma with wild-type and indicated
Ala-substitution mutants of YAe62.8 Va and Vb and measuring the ability of
the transductants to respond to ligands and bind tetramers as previously
described (Rubtsova et al., 2009; Scott-Browne et al., 2007).
ACCESSION NUMBERS
The coordinates of the YAe62 TCR bound to Kb-pWM have been deposited in
the Protein Data Bank under the accession ID 3RGV.32 Immunity 35, 23–33, July 22, 2011 ª2011 Elsevier Inc.SUPPLEMENTAL INFORMATION
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